Exposure to chloroquine in male adults and children aged 9-11 years with malaria due to Plasmodium vivax

Trans R Soc Trop Med Hyg. 2021 Jan 7;115(1):38-42. doi: 10.1093/trstmh/traa079.

Abstract

Background: Chloroquine is effective against the asexual blood stage of Plasmodium vivax. A high proportion of children are underdosed with the drug, but there are no studies comparing chloroquine exposure in adults and children aged 8-11 years old. The present study intends to compare these populations using the area under the curve (AUC) derived from the plasma concentration-time profile in patients with P. vivax.

Methods: A prospective study of cases was performed on male children (aged 9-11 years) and adults with vivax malaria. Blood samples were collected after several days of treatment. Chloroquine was measured by high-performance liquid chromatography. A non-compartmental pharmacokinetic model was used to calculate the pharmacokinetic parameters of the drug.

Results: A total of 20 children and 25 adults were included in the study. Plasma concentrations of chloroquine in older children ranged from 67 to 1112 ng/ml, and in adults the value ranged from 74 to 1147 ng/ml. The AUC to the last measurable concentration and to infinite was significantly lower in children than in adults, indicating a lower exposure to the drug.

Conclusion: These data demonstrate lower exposure to chloroquine in children, which corroborates the importance of optimising the doses of chloroquine in the study age band to ensure adequate exposure to the drug.

Keywords: anti-malarial drugs; chloroquine; exposure; malaria; pharmacokinetics.

MeSH terms

  • Adult
  • Antimalarials* / pharmacology
  • Antimalarials* / therapeutic use
  • Child
  • Chloroquine / therapeutic use
  • Drug Resistance
  • Humans
  • Malaria* / drug therapy
  • Malaria, Vivax* / drug therapy
  • Male
  • Plasmodium vivax
  • Prospective Studies

Substances

  • Antimalarials
  • Chloroquine